AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $157,000 | -9.2% | 15,000 | -10.1% | 0.00% | 0.0% |
Q2 2022 | $173,000 | +7.5% | 16,685 | -2.0% | 0.00% | 0.0% |
Q1 2022 | $161,000 | -73.7% | 17,032 | -67.9% | 0.00% | -66.7% |
Q4 2021 | $613,000 | +32.4% | 53,118 | +9.5% | 0.01% | 0.0% |
Q3 2021 | $463,000 | +30.4% | 48,497 | +31.6% | 0.01% | +20.0% |
Q2 2021 | $355,000 | +7000.0% | 36,858 | +10552.6% | 0.01% | – |
Q1 2019 | $5,000 | +66.7% | 346 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | – | 346 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |